AR affects the expression of several kinases and phosphatases, and results from phoshoproteome studies indicate active signaling in prostate cancer and CRPC by several kinases that might represent viable therapeutic targets, such as YAP1 and PAK2 (reviewed in [67]). The gene discussed is AR; the disease is prostate cancer.